T&T has received 1,688,120 doses of a WHO-approved COVID-19 vaccine to date, enough vaccines to fully vaccinate 952,070 people.
To date, T&T has administered 51% of the available stock, with 824,548 doses of Sinopharm, AstraZeneca, Pfizer, and Johnson & Johnson vaccines remaining.
However, the country's vaccination rate is dwindling yet again.
This past month's surge in vaccinations was largely driven by the first doses administered in mid/late July receiving their second doses mid-August.
Vaccines
The 7-day rolling average is now at 10,846 doses/day.
T&T's eligible population for a COVID-19 vaccine has risen to 1,114,095 as children between 12-18 and pregnant mothers became eligible.
The country is 56.6% of the way there to "herd immunity" based on first doses and 42.9% of the way there based on second doses.
Vaccines
